参考文献:1. O’Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics. 2009;27:95-12. CrossRef 2. Charles A. Advances in the basic and clinical science of migraine. Ann Neurol. 2009;65:491-. CrossRef 3. Stewart WF, Wood GC, Razzaghi H, et al. Work impact of migraine headaches. J Occup Environ Med. 2008;50:736-5. CrossRef 4. Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache. 1998;38:87-6. CrossRef 5. Hazard E, Munakata J, Bigal ME, et al. The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis. Value Health. 2009;12:55-4. CrossRef 6. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey. Headache. 2003;43:19-6. CrossRef 7. Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol. 2008;63:148-8. CrossRef 8. Schwedt TJ, Krauss MJ, Frey K, Gereau 4th RW. Episodic and chronic migraineurs are hypersensitive to thermal stimuli between migraine attacks. Cephalalgia. 2011;31:6-2. CrossRef 9. Oshinsky ML, Gomonchareonsiri S. Episodic dural stimulation in awake rats: a model for recurrent headache. Headache. 2007;47:1026-6. CrossRef 10. Edelmayer RM, Vanderah TW, Majuta L, et al. Medullary pain facilitating neurons mediate allodynia in headache-related pain. Ann Neurol. 2009;65:184-3. CrossRef 11. Pradhan AA, Smith ML, McGuire B, et al. Characterization of a novel model of chronic migraine. Pain. 2014;155:269-4. / First animal model described for chronic migraine pain. 12. Leknes S, Tracey I. A common neurobiology for pain and pleasure. Nat Rev Neurosci. 2008;9:314-0. CrossRef 13. Marbach JJ, Lund P. Depression, anhedonia and anxiety in temporomandibular joint and other facial pain syndromes. Pain. 1981;11:73-4. CrossRef 14. Nicholson B, Verma S. Comorbidities in chronic neuropathic pain. Pain Med. 2004;5 Suppl 1:S9–S27. CrossRef 15. Asmundson GJ, Katz J. Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress Anxiety. 2009;26:888-01. CrossRef 16. Elman I, Borsook D, Volkow ND. Pain and suicidality: insights from reward and addiction neuroscience. Prog Neurobiol. 2013;109:1-7. CrossRef 17. Juurlink DN, Herrmann N, Szalai JP, et al. Medical illness and the risk of suicide in the elderly. Arch Intern Med. 2004;164:1179-4. CrossRef 18. Ilgen MA, Kleinberg F, Ignacio RV, et al. Noncancer pain conditions and risk of suicide. JAMA Psychiatry. 2013;70:692-. CrossRef 19. Jarcho JM, Mayer EA, Jiang ZK, et al. Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain. 2012;153:744-4. CrossRef 20. Fields HL, Hjelmstad GO, Margolis EB, Nicola SM. Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu Rev Neurosci. 2007;30:289-16. CrossRef 21. McCutcheon JE, Ebner SR, Loriaux AL, Roitman MF. Encoding of aversion by dopamine and the nucleus accumbens. Front Neurosci. 2012;6:137. CrossRef 22. Shippenberg TS, Bals-Kubik R, Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther. 1993;265:53-. 23. Knoll AT, Muschamp JW, Sillivan SE. Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol Psychiatry. 2001;70:425-3. CrossRef 24. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther. 1993;264:489-5. 25. Chefer VI, B?ckman CM, Gigante ED, Shippenberg TS. Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion. Neuropsychopharmacology. 2013;38:2623-1. CrossRef 26. Land BB, Bruchas MR, Schattauer S, et al. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci U S A. 2009;106:19168-3. CrossRef 27. Stevenson CW, Sullivan RM, Gratton A. Effects of basolateral amygdala dopamine depletion on the nucleus accumbens and medial prefrontal cortical dopamine responses to stress. Neuroscience. 2003;116:285-3. CrossRef 28. McCullough LD, Sokolowski JD, Salamone JD. A neurochemical and behavioral investigation of the involvement of nucleus accumbens dopamine in instrumental avoidance. Neuroscience. 1993;52:919-5. CrossRef 29. Geha PY, Baliki MN, Chialvo DR, et al. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain. 2007;128:88-00. CrossRef 30. Zubieta JK, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci. 2009;1156:198-10. CrossRef 31. Lammel S, Lim BK, Ran C, et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature. 2012;491:212-. / This paper dissected the reward and aversive circuitry originating in the ventral tegmental area. CrossRef 32. Carr DB, Sesack SR. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci. 2000;20:3864-3. 33. Maleki N, Becerra L, Nutile L, et al. Migraine attacks the basal ganglia. Mol Pain. 2011;7:71. CrossRef 34. Liu ZH, Shin R, Ikemoto S. Dual role of medial A10 dopamine neurons in affective encoding. Neuropsychopharmacology. 2008;33:3010-0. CrossRef 35. Minami M. Neuronal mechanisms for pain-induced aversion behavioral studies using a conditioned place aversion test. Int Rev Neurobiol. 2009;85:135-4. CrossRef 36. King T, Vera-Portocarrero L, Gutierrez T, et al. Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci. 2009;12:1364-. CrossRef 37. Navratilova E, Xie JY, King T, Porreca F. Evaluation of reward from pain relief. Ann N Y Acad Sci. 2013;1282:1-1. CrossRef 38. De Felice M, Eyde N, Dodick D, et al. Capturing the aversive state of cephalic pain preclinically. Ann Neurol. 2013. doi:10.1002/ana.23922 . / First demonstration of pain aversion and contribution of the ACC in a model of migraine pain. 39. Barbanti P, Fofi L, Aurilia C, Egeo G. Dopaminergic symptoms in migraine. Neurol Sci. 2013;34 Suppl 1:S67-0. CrossRef 40. Da Silva AN, Tepper SJ. Acute treatment of migraines. CNS Drugs. 2012;26:823-9. CrossRef 41. Marmura MJ. Use of dopamine antagonists in treatment of migraine. Curr Treat Options Neurol. 2012;14:27-5. CrossRef 42. Castillo J, Martínez F, Suárez C. Cerebrospinal fluid tyrosine and 3,4-dihydroxyphenylacetic acid levels in migraine patients. Cephalalgia. 1996;16:56-1. CrossRef 43. Mitsikostas DD, Papadopoulou-Daifotis Z, Sfikakis A, Varonos D. The effect of sumatriptan on brain monoamines in rats. Headache. 1996;36:29-1. CrossRef 44. Ghosh J, Pradhan S, Mittal B. Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility. Neuromol Med. 2013;15:61-3. CrossRef 45. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9:463-4. CrossRef 46. Hofbauer RK, Rainville P, Duncan GH, Bushnell MC. Cortical representation of the sensory dimension of pain. J Neurophysiol. 2001;86:402-1. 47. Rainville P, Duncan GH, Price DD, et al. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science. 1997;277:968-1. CrossRef 48. Qu C, King T, Okun A, et al. Lesion of the rostral anterior cingulate cortex eliminates the aversiveness of spontaneous neuropathic pain following partial or complete axotomy. Pain. 2011;152:1641-. CrossRef 49. Johansen JP, Fields HL, Manning BH. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci U S A. 2001;98:8077-2. CrossRef 50. Gao YJ, Ren WH, Zhang YQ, Zhao ZQ. Contributions of the anterior cingulate cortex and amygdala to pain- and fear-conditioned place avoidance in rats. Pain. 2004;110:343-3. / One of the initial studies demonstrating the importance of the ACC in pain aversion in a rodent model of persistent pain. CrossRef 51. Donahue RR, LaGraize SC, Fuchs PN. Electrolytic lesion of the anterior cingulate cortex decreases inflammatory, but not neuropathic nociceptive behavior in rats. Brain Res. 2001;897:131-. CrossRef 52. Ren LY, Lu ZM, Liu MG, et al. Distinct roles of the anterior cingulate cortex in spinal and supraspinal bee venom-induced pain behaviors. Neuroscience. 2008;153:268-8. CrossRef 53. Koyama T, Kato K, Mikami A. During pain-avoidance neurons activated in the macaque anterior cingulate and caudate. Neurosci Lett. 2000;283:17-0. CrossRef 54. LaGraize SC, Labuda CJ, Rutledge MA, et al. Differential effect of anterior cingulate cortex lesion on mechanical hypersensitivity and escape/avoidance behavior in an animal model of neuropathic pain. Exp Neurol. 2004;188:139-8. CrossRef 55. Arnsten AF. Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009;10:410-2. CrossRef 56. Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12:652-9. CrossRef 57. Pujara M, Koenigs M. Mechanisms of reward circuit dysfunction in psychiatric illness: prefrontal-striatal interactions. Neuroscientist. 2014;20:82-5. 58. Granziera C, DaSilva AF, Snyder J, et al. Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med. 2006;3:e402. CrossRef 59. DaSilva AF, Granziera C, Snyder J, Hadjikhani N. Thickening in the somatosensory cortex of patients with migraine. Neurology. 2007;69:1990-. CrossRef 60. Maleki N, Becerra L, Brawn J, et al. Concurrent functional and structural cortical alterations in migraine. Cephalalgia. 2012;32:607-0. CrossRef 61. Kim JH, Kim S, Suh SI, et al. Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study. Cephalalgia. 2010;30:53-1. 62. Bushnell MC, Ceko M, Low LA. Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci. 2013;14:502-1. CrossRef 63. Goldstein RZ, Craig AD, Bechara A, et al. The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci. 2009;13:372-0. CrossRef 64. Ortega-Legaspi JM, Gortari P, Gardu?o-Gutiérrez R, et al. Expression of the dopaminergic D1 and D2 receptors in the anterior cingulate cortex in a model of neuropathic pain. Mol Pain. 2011;7:97. CrossRef 65. Jensen KB, Kosek E, Petzke F, et al. Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain. Pain. 2009;144:95-00. CrossRef 66. Burgmer M, Pogatzki-Zahn E, Gaubitz M, et al. Fibromyalgia unique temporal brain activation during experimental pain: a controlled fMRI study. J Neural Transm. 2010;117:123-1. CrossRef 67. Berman SM, Naliboff BD, Suyenobu B, et al. Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J Neurosci. 2008;28:349-9. CrossRef 68. Baliki MN, Chialvo DR, Geha PY, et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci. 2006;26:12165-3. CrossRef 69. Jin C, Yuan K, Zhao L, et al. Structural and functional abnormalities in migraine patients without aura. NMR Biomed. 2013;26:58-4. CrossRef 70. Kim JH, Suh SI, Seol HY, et al. Regional grey matter changes in patients with migraine: a voxel-based morphometry study. Cephalalgia. 2008;28:598-04. CrossRef 71. Eck J, Richter M, Straube T, et al. Affective brain regions are activated during the processing of pain-related words in migraine patients. Pain. 2011;152:1104-3. CrossRef 72. Xue T, Yuan K, Cheng P, et al. Alterations of regional spontaneous neuronal activity and corresponding brain circuit changes during resting state in migraine without aura. NMR Biomed. 2013;26:1051-. CrossRef 73. Salvadore G, Nugent AC, Lemaitre H, et al. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage. 2011;54:2643-1. CrossRef 74. Sprengelmeyer R, Steele JD, Mwangi B, et al. The insular cortex and the neuroanatomy of major depression. J Affect Disord. 2011;133:120-. CrossRef 75. Parkinson JA, Willoughby PJ, Robbins TW, Everitt BJ. Disconnection of the anterior cingulate cortex and nucleus accumbens core impairs Pavlovian approach behavior: further evidence for limbic cortical-ventral striatopallidal systems. Behav Neurosci. 2000;114:42-3. CrossRef 76. Wacker J, Dillon DG, Pizzagalli DA. The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques. Neuroimage. 2009;46:327-7. CrossRef 77. Becerra L, Navratilova E, Porreca F, Borsook D. Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans. J Neurophysiol. 2013;110:1221-. CrossRef 78. Cauda F, Cavanna AE, D’agata F, et al. Functional connectivity and coactivation of the nucleus accumbens: a combined functional connectivity and structure-based meta-analysis. J Cogn Neurosci. 2011;23:2864-7. CrossRef 79. Borsook D, Edwards R, Elman I, et al. Pain and analgesia: the value of salience circuits. Prog Neurobiol. 2013;104:93-05. CrossRef 80. Kringelbach ML. The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci. 2005;6:691-02. CrossRef 81. Antonaci F, Nappi G, Galli F, et al. Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain. 2011;12:115-5. CrossRef 82. Buse D, Silberstein SD, Manack AN, Papapetropoulos S, Lipton RB. Psychiatric comorbidities of episodic and chronic migraine. J Neurol. 2013;260:1960-. CrossRef 83. Ratcliffe GE, Enns MW, Jacobi F, et al. The relationship between migraine and mental disorders in a population-based sample. Gen Hosp Psychiatry. 2009;31:14-. CrossRef 84. Jette N, Patten S, Williams J, et al. Comorbidity of migraine and psychiatric disorders–a national population-based study. Headache. 2008;48:501-6. CrossRef 85. Theeler BJ, Kenney K, Prokhorenko OA, et al. Headache triggers in the US military. Headache. 2010;50:790-. CrossRef 86. Burstein R, Jakubowski M. Neural substrate of depression during migraine. Neurol Sci. 2009;30 Suppl 1:S27-1. CrossRef 87. Borsook D, Maleki N, Becerra L, McEwen B. Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron. 2012;73:219-4. CrossRef 88. Maleki N, Becerra L, Borsook D. Migraine: maladaptive brain responses to stress. Headache. 2012;52 Suppl 2:102-. CrossRef 89. Shurman J, Koob GF, Gutstein HB. Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain. Pain Med. 2010;11:1092-. CrossRef 90. Bie B, Brown DL, Naguib M. Synaptic plasticity and pain aversion. Eur J Pharmacol. 2011;667:26-1. CrossRef 91. Tanimoto S, Nakagawa T, Yamauchi Y. Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur J Neurosci. 2003;18:2343-0. CrossRef 92. Jennings JH, Sparta DR, Stamatakis AM, et al. Distinct extended amygdala circuits for divergent motivational states. Nature. 2013;496:224-. CrossRef 93. Murray EA. The amygdala, reward and emotion. Trends Cogn Sci. 2007;11:489-7. CrossRef 94. Akcali D, Sayin A, Sara Y, Bolay H. Does single cortical spreading depression elicit pain behaviour in freely moving rats? Cephalalgia. 2010;30:1195-06. CrossRef 95. Lauritzen M, Dreier JP, Fabricius M, et al. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab. 2011;31:17-5. CrossRef 96. Charles AC, Baca SM. Cortical spreading depression and migraine. Nat Rev Neurol. 2013;9:637-4. CrossRef 97. Hadjikhani N, Ward N, Boshyan J, et al. The missing link: enhanced functional connectivity between amygdala and visceroceptive cortex in migraine. Cephalalgia. 2013;33:1264-. CrossRef 98. Dehbandi S, Speckmann EJ, Pape HC, Gorji A. Cortical spreading depression modulates synaptic transmission of the rat lateral amygdala. Eur J Neurosci. 2008;27:2057-5. CrossRef 99. Stankewitz A, May A. Increased limbic and brainstem activity during migraine attacks following olfactory stimulation. Neurology. 2011;77:476-2. CrossRef
作者单位:Catherine M. Cahill (1) Christopher Cook (3) Sarah Pickens (2)
1. Department of Anesthesiology & Perioperative Care, 837 Health Sciences Rd, 2117 Gillespie Neuroscience Research Facility, Irvine, CA, 92697, USA 3. Department of Pharmacology, University of California, Irvine, 2226, Gillespie Neuroscience Research Facility, Irvine, CA, 92617, USA 2. Department of Anesthesiology & Perioperative Care, University of California, Irvine, 2226, Gillespie Neuroscience Research Facility, Irvine, CA, 92617, USA
ISSN:1534-3081
文摘
Migraine is a debilitating neurological disorder with grave consequences for both the individual and society. This review will focus on recent literature investigating how brain structures implicated in reward and aversion contribute to the genesis of migraine pain. There exist many overlapping and interacting brain regions within pain and reward circuitry that contribute to negative affect and subjective experience of pain. The emotional component of pain has been argued to be a greater metric of quality of life than its sensory component, and thus understanding the processes that influence this pain characteristic is essential to developing novel treatment strategies for mitigating migraine pain. We emphasize and provide evidence that abnormalities within the mesolimbic cortical reward pathways contribute to migraine pain and that there are structural and functional neuroplasticity within the overlapping brain regions common to both pain and reward.